Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.31 USD | -3.50% | -10.05% | +99.40% |
May. 30 | Cantor Fitzgerald Initiates ADC Therapeutics at Overweight Rating | MT |
May. 07 | HC Wainwright Adjusts Price Target on ADC Therapeutics to $8 From $9, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.40% | 330M | |
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- ADCT Stock
- News ADC Therapeutics SA
- RBC Cuts Price Target on ADC Therapeutics to $20 From $25, Notes Delay in Potential Cami Launch; Maintains Outperform, Speculative Risk Rating